Picture of The Chemours logo

CC — The Chemours News Story

0.000.00%
us flag iconLast trade - 00:00
Basic MaterialsAdventurousMid CapContrarian

Chemours Q2 sales flat as lower volumes weigh on results

Chemours Q2 sales flat as lower volumes weigh on results


Overview

  • US industrial chemicals maker's Q2 sales were flat yr/yr and missed analyst expectations

  • Adjusted EPS for Q2 met analyst expectations

  • Adjusted net income and adjusted EBITDA for Q2 beat analyst estimates


Outlook

  • Chemours expects Q3 adjusted EBITDA between $175 mln and $205 mln

  • Company maintains 2026 adjusted EBITDA outlook of $775 mln to $825 mln

  • Chemours sees 2026 net sales growing 1% to 5% over 2025


Result Drivers

  • VOLUME DECLINES - Co said lower volumes, particularly in TSS aftermarket refrigerants and APM due to a line closure, weighed on sales

  • PRICING ACTIONS - Price increases across all segments, especially in Titanium Technologies, helped offset volume declines

  • HIGHER COSTS - Adjusted EBITDA was impacted by higher costs related to a resolved outage at the Washington Works site and lower sales from the APM line closure


Company press release: ID:nPn7zhylna


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Sales

Miss

$1.60 bln

$1.65 bln (7 Analysts)

Q2 Adjusted EPS

Meet

$0.42

$0.42 (9 Analysts)

Q2 Loss Per Share

$1.81

Q2 Adjusted Net Income

Beat

$64 mln

$60.68 mln (6 Analysts)

Q2 Adjusted EBITDA

Beat

$247 mln

$238.07 mln (8 Analysts)


Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy", 4 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the diversified chemicals peer group is "buy."

  • Wall Street's median 12-month price target for Chemours Co is $25.50, about 49% above its August 3 closing price of $17.11

  • The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 16 three months ago


Reuters Recommended Reads

  • Aug 4 - DuPont narrows annual sales forecast on water business weakness, shares down

  • Aug 4 - Celanese Q2 adjusted EPS beats estimates, sales meet expectations

  • Aug 4 - Germany's Evonik Q2 revenue up 11% on higher volumes and prices


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on The Chemours

See all news